1 unknown. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
Follow Refractory AML: new trials by email Literature Review of Refractory AML trials Research Report on Refractory AML
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Early Phase Study of NEI-01 in Patients With Solid Tumors or Acute Myeloid Leukemia NEI-01 - Advanced Solid Tumor, Relapsed AML | Phase 1 | Unknown | New Epsilon Innovation Limited | 24 | 2022-04-25 | 2023-07-27 |
Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Leukemia (1) · Leukemia, Myeloid (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
New Epsilon Innovation Limited (1)
Hong Kong (1)